Abstract

Accumulating evidences have documented that angiogenesis is closely linked to inflammation and regulators of angiogenesis play key roles in various inflammatory conditions. PlGF is an angiogenic protein belonging to the VEGF family and is upregulated mainly in pathologic conditions. Recently, PlGF was discovered having a proinflammatory role in inflammatory arthritis and its serum level drew attention not only as a useful surrogate biomarker but also a potential therapeutic target in atherosclerosis and various cancers. Particularly, PlGF has attractive clinical values because endogenous PlGF is redundant for vascular development and physiological vessel maintenance in healthy adults. However, there have been conflicting results about the efficacy of PlGF inhibition depending on the experimental and clinical settings. Further close investigations for resolving the puzzle of PlGF biology are required.

Highlights

  • Inflammation is a complex set of interaction between soluble factors and cells that can arise in any tissue in response to traumatic, infectious, postischemic, toxic or autoimmune injuries

  • We discuss the distinctive role of placenta growth factor (PlGF) in the mediation of angiogenic and inflammatory signaling in cancer and atherosclerosis, in which inflammation plays a key role as a positive or negative regulator, and rheumatoid arthritis, a representative of chronic inflammatory diseases

  • PlGF lies dormant in the normal healthy state and becomes active in the presence of pathologic conditions, such as, those associated with chronic inflammatory diseases

Read more

Summary

Introduction

Inflammation is a complex set of interaction between soluble factors and cells that can arise in any tissue in response to traumatic, infectious, postischemic, toxic or autoimmune injuries. We discuss the distinctive role of PlGF in the mediation of angiogenic and inflammatory signaling in cancer and atherosclerosis, in which inflammation plays a key role as a positive or negative regulator, and rheumatoid arthritis, a representative of chronic inflammatory diseases.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.